NCPA Joins Pharmacy Compounding Groups to Address Drug Shortages During COVID-19

On Monday, NCPA joined PCCA and other pharmacy groups in a letter to Vice President Mike Pence, HHS Secretary Alex Azar, CMS Administrator Seema Verma, and FDA Commissioner Hahn emphasizing the need for patient access to medications — both those provided by the pharmaceutical manufacturers and those provided by pharmacists through compounding — during the COVID-19 public health emergency that are now in short supply due to ongoing drug shortages. Our groups asked FDA, CMS, and HHS to review certain provisions that may be hindering pharmacists' ability to compound medically necessary drugs during the COVID-19 public health emergency. NCPA will continue to advocate for compounding pharmacies to enhance their participation in addressing the COVID-19 crisis.